Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?

Adjuvant and neo-adjuvant therapy

Date

17 Oct 2020

Session

Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?

Topics

Cytotoxic Therapy

Tumour Site

Melanoma

Presenters

Georgina Long

Authors

G.V. Long

Author affiliations

  • Melanoma Institute Australia, 2065 - Wollstonecraft/AU

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Q&A and live discussion

Presenter: Christian Blank

Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.